{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:53:06Z","timestamp":1786737186502,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/ijd.ijd_385_19","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T06:44:28Z","timestamp":1597041868000},"page":"423","source":"Crossref","is-referenced-by-count":4,"title":["Antifungal resistance of candida species isolated from HIV patients in a tertiary care hospital, Mysuru, Karnataka"],"prefix":"10.4103","volume":"65","author":[{"given":"MN","family":"Sumana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umamaheshwari","family":"Shivaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0019-5154.291802-1","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/JCM.42.4.1519-1527.2004","article-title":"Incidence of bloodstream infections due to Candidaspecies and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program","author":"Hajjeh","year":"2004","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0019-5154.291802-2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4314\/ajcem.v17i3.5","article-title":"Species distribution and antifungal susceptibility pattern of Candida isolates from pregnant women in a tertiary hospital in Nigeria","author":"Efunshile","year":"2016","journal-title":"Afr J Clin Exper Microbiol"},{"key":"key-10.4103\/0019-5154.291802-3","unstructured":"Centers for Disease Control and Prevention. Antifungal Resistance. Available from: https:\/\/www.cdc.gov\/fungal\/antifungal-resistance.html. [Last accessed on 2018 Dec 18]."},{"key":"key-10.4103\/0019-5154.291802-4","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/AAC.01128-10","article-title":"Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: A prospective multicenter study involving 2,441 patients","author":"Lortholary","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0019-5154.291802-5","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1128\/AAC.00019-12","article-title":"Impact of prior inappropriate fluconazole dosing on isolation of fluconazole-nonsusceptible Candida species in hospitalized patients with candidemia","author":"Shah","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0019-5154.291802-6","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1128\/AAC.05947-11","article-title":"Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection","author":"Ben-Ami","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0019-5154.291802-7","first-page":"278","article-title":"A study of candidiasis in HIV reactive patients in a tertiary care hospital, Mysore-South India","author":"Shivaswamy","year":"2014","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0019-5154.291802-8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11046-012-9593-0","article-title":"Pseudomembranous candidiasis in HIV\/AIDS patients in Cali, Colombia","author":"Castro","year":"2013","journal-title":"Mycopathologia"},{"key":"key-10.4103\/0019-5154.291802-9","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1128\/JCM.42.3.1260-1262.2004","article-title":"Susceptibility pattern and molecular type of species-specific Candida in oropharyngeal lesions of Indian human immunodeficiency virus-positive patients","author":"Lattif","year":"2004","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0019-5154.291802-10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1007237711099","article-title":"In vitro susceptibility of 137 Candida sp.isolates from HIV positive patients to several antifungal drugs","author":"Magaldi","year":"2001","journal-title":"Mycopathologia"},{"key":"key-10.4103\/0019-5154.291802-11","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/S0140-6736(07)60284-0","article-title":"Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: Informing urgent policy changes","author":"Getahun","year":"2007","journal-title":"Lancet"},{"key":"key-10.4103\/0019-5154.291802-12","first-page":"177","article-title":"Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients","author":"Maninder","year":"2008","journal-title":"J Commun Dis"},{"key":"key-10.4103\/0019-5154.291802-13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1439-0507.2008.01542.x","article-title":"Oral yeast carriage in HIV-infected and non-infected populations in Rosario, Argentina","author":"Luque","year":"2009","journal-title":"Mycoses"},{"key":"key-10.4103\/0019-5154.291802-14","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3343\/alm.2012.32.6.426","article-title":"Antifungal susceptibility to amphotericin B, fluconazole, voriconazole, and flucytosine in Candida bloodstream isolates from 15 tertiary hospitals in Korea","author":"Jung","year":"2012","journal-title":"Ann Lab Med"},{"key":"key-10.4103\/0019-5154.291802-15","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1128\/JCM.41.12.5729-5731.2003","article-title":"Caspofungin activity against clinical isolates of fluconazole-resistant Candida","author":"Pfaller","year":"2003","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0019-5154.291802-16","first-page":"1831","article-title":"The antifungal susceptibilities of oral Candida spp.isolates from HIV-infected patients","author":"Satana","year":"2010","journal-title":"Afr J Microbiol Res"},{"key":"key-10.4103\/0019-5154.291802-17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0732-8893(02)00440-6","article-title":"Antifungal susceptibility of South African oral yeast isolates from HIV\/AIDS patients and healthy individuals","author":"Blignaut","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key-10.4103\/0019-5154.291802-18","first-page":"479","article-title":"Oral HIV lesions and oral health behaviour of HIV-positive patients attending the Queen Elizabeth II Hospital, Maseru, Lesotho","author":"Kamiru","year":"2002","journal-title":"SADJ"},{"key":"key-10.4103\/0019-5154.291802-19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1130-1406(05)70014-0","article-title":"Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV\/AIDS patients and healthy persons","author":"S\u00e1nchez-Vargas","year":"2005","journal-title":"Rev Iberoam Micol"},{"key":"key-10.4103\/0019-5154.291802-20","doi-asserted-by":"crossref","unstructured":"Pfaller MA, Boyken L, Hollis RJ, Messer SA, Tendolkar S, Diekema DJ. In vitro susceptibilities of Candida spp. to caspofungin: Four years of global surveillance. J Clin Microbiol 2006;44:760-3.","DOI":"10.1128\/JCM.44.3.760-763.2006"},{"key":"key-10.4103\/0019-5154.291802-21","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1128\/JCM.39.9.3254-3259.2001","article-title":"International surveillance of bloodstream infections due to Candida species: Frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program","author":"Pfaller","year":"2001","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0019-5154.291802-22","first-page":"135","article-title":"Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis","author":"Hamza","year":"208;","journal-title":"BMC Microbiol"},{"key":"key-10.4103\/0019-5154.291802-23","first-page":"227","article-title":"Detection of Candida dubliniensis in Venezuela","author":"Hartung","year":"2005","journal-title":"Mycopathologia"},{"key":"key-10.4103\/0019-5154.291802-24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4103\/0377-4929.56138","article-title":"Detection and antifungal susceptibility testing of oral Candidadubliniensis from human immunodeficiency virus-infected patients","author":"Chunchanur","year":"2009","journal-title":"Indian J Pathol Microbiol","ISSN":"https:\/\/id.crossref.org\/issn\/0377-4929","issn-type":"print"},{"key":"key-10.4103\/0019-5154.291802-25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1399-302X.2005.00236.x","article-title":"In vitro susceptibility of oral Candida to seven antifungal agents","author":"Kuriyama","year":"2005","journal-title":"Oral Microbiol Immunol"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:51:06Z","timestamp":1786733466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.IJD_385_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"alternative-id":["291802"],"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_385_19","relation":{},"ISSN":["0019-5154"],"issn-type":[{"value":"0019-5154","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}